KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Ionis Pharmaceuticals (IONS) over the last 13 years, with Q3 2025 value amounting to $5.1 million.

  • Ionis Pharmaceuticals' Amortizatization of Intangibles fell 4436.54% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.5 million, marking a year-over-year decrease of 2517.95%. This contributed to the annual value of $37.7 million for FY2024, which is 3063.18% up from last year.
  • As of Q3 2025, Ionis Pharmaceuticals' Amortizatization of Intangibles stood at $5.1 million, which was down 4436.54% from $5.9 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $9.9 million for Q2 2024, and its period low was -$4.8 million during Q2 2021.
  • In the last 5 years, Ionis Pharmaceuticals' Amortizatization of Intangibles had a median value of $5.1 million in 2025 and averaged $3.1 million.
  • As far as peak fluctuations go, Ionis Pharmaceuticals' Amortizatization of Intangibles crashed by 27881.36% in 2021, and later surged by 75684.65% in 2023.
  • Over the past 5 years, Ionis Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$4.3 million in 2021, then surged by 139.5% to $1.7 million in 2022, then skyrocketed by 404.4% to $8.5 million in 2023, then increased by 11.32% to $9.4 million in 2024, then tumbled by 46.19% to $5.1 million in 2025.
  • Its Amortizatization of Intangibles stands at $5.1 million for Q3 2025, versus $5.9 million for Q2 2025 and $7.1 million for Q1 2025.